Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL review.
enabling formulation
in silico prediction
poorly water-soluble drug
solubility parameter
Journal
The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
21
02
2018
accepted:
28
05
2018
pubmed:
7
7
2018
medline:
26
4
2019
entrez:
7
7
2018
Statut:
ppublish
Résumé
Solubility parameters have been used for decades in various scientific fields including pharmaceutics. It is, however, still a field of active research both on a conceptual and experimental level. This work addresses the need to review solubility parameter applications in pharmaceutics of poorly water-soluble drugs. An overview of the different experimental and calculation methods to determine solubility parameters is provided, which covers from classical to modern approaches. In the pharmaceutical field, solubility parameters are primarily used to guide organic solvent selection, cocrystals and salt screening, lipid-based delivery, solid dispersions and nano- or microparticulate drug delivery systems. Solubility parameters have been applied for a quantitative assessment of mixtures, or they are simply used to rank excipients for a given drug. In particular, partial solubility parameters hold great promise for aiding the development of poorly soluble drug delivery systems. This is particularly true in early-stage development, where compound availability and resources are limited. The experimental determination of solubility parameters has its merits despite being rather labour-intensive because further data can be used to continuously improve in silico predictions. Such improvements will ensure that solubility parameters will also in future guide scientists in finding suitable drug formulations.
Substances chimiques
Excipients
0
Lipids
0
Pharmaceutical Preparations
0
Solvents
0
Water
059QF0KO0R
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
441-463Subventions
Organisme : European Union's Horizon 2020 Research and Innovation Programme
ID : 674909
Informations de copyright
© 2018 Royal Pharmaceutical Society.